Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 100 /hr

★★★★★

☆☆☆☆☆

Hire Sheila A.

United States

USD 100 /hr

Freelance Machine Learning & Data Scientist | Scientific Insight Analyst (Life Sciences)

Profile Summary

I am passionate about leveraging my deep expertise in bioinformatics, machine learning and AI to transform complex data into actionable insights that advance human and animal health. I am a freelance data scientist and technical scientific writer with a PhD-level molecular microbiology foundation in infectious diseases and immunology and computational biology. Past projects include bioinformatics platform development (Python, R, AWS) and analyses (including bulk RNAseq, whole genome, microbiome). My current projects involve Rapid Literature Review, Evidence Landscape Synthesis Reports, Mechanism-of-Action Research. My machine learning projects have included analyses of diabetes and heart disease risk, Parkinson's Disease, Influenza pathogenesis, bovine and swine respiratory disease progression mechanisms.

Subject Matter Expertise

• ★ Machine Learning
• ★ Technical & Scientific Writing
• ★ Science Communication
• ☆ Microbiology
• ☆ Microbiome Research
• ☆ Molecular Biology
• ☆ Next Generation Sequencing (NGS)
• ☆ Data Analysis
• ☆ Artificial Intelligence
• ☆ Bioinformatics
• ☆ Python
• ☆ R
• ☆ Infectious Disease
• ☆ Public Health
• ☆ Experimental Protocols
• ☆ White Papers
• ☆ Literature Review
• ☆ Systematic Literature Review

Services

• Writing
• Research
• Consulting
• Data & AI

Writing Medical Writing, Technical Writing

Research Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review

Consulting Scientific and Technical Consulting

Data & AI Data Insights

Work Experience

Freelance Data Science & Consulting

Freelance Data Science & Consulting

May 2025 - Present

Senior Bioinformatics Scientist II

Resilient Biotics

October 2018 - Present

Education

PhD Infectious Disease & Immunity (Infectious Disease & Immunity)

University of California at Berkeley

August 2011 - May 2015

Masters of Public Health, Infectious Disease (Public Health, Infectious Disease & Epidemiology)

University of California, Berkeley

August 2009 - May 2011

Masters Organization Development (Business and Pyschology)

Sonoma State University

August 1997 - May 1999

Certifications

• AI Engineering Essentials I

  SuperDataScience

  https://credsverse.com/credentials/42e851d6-fa10-48aa-8622-5b8f8a42c11d

  September 2025 - Present

• LLM/GenAI

  SuperDataScience

  https://credsverse.com/credentials/197d28d8-6278-45f3-a9aa-cc381c2207cc

  August 2025 - Present

• GCP for Clinical Trials with Investigational Drugs and Medical Devices - U.S. FDA Focus

  CITI

  https://www.citiprogram.org/verify/?wfe69ce96-03ac-486b-977a-fa4576325428-70789902

  July 2025 - Present

• Good Manufacturing Practices (GMP)

  CITI

  https://www.citiprogram.org/verify/?w6a679a71-4c79-4d09-abc8-3379a250595e-70789903

  July 2025 - Present

• Certified ScrumMaster

  Scrum Alliance

  https://bcert.me/bc/html/show-badge.html?b=kejsvmku

  June 2025 - Present

Publications

JOURNAL ARTICLE

Yuan Hu Allegretti, Reina Yamaji, Sheila Adams-Sapper, Lee W. Riley (2024). Genetic features of antimicrobial drug-susceptible extraintestinal pathogenic <i>Escherichia coli</i> pandemic sequence type 95 . Microbiology Spectrum.

Nicole Jackson, Cheyenne R. Belmont, Nicole J. Tarlton, Yuan Hu Allegretti, Sheila Adams-Sapper, Yolanda Yue Huang, Clarissa A. Borges, Bradley W. Frazee, Danka Florence-Petrovic, Clarisse Hufana, et al. (2022). Genetic Predictive Factors for Nonsusceptible Phenotypes and Multidrug Resistance in Expanded-Spectrum Cephalosporin-Resistant Uropathogenic Escherichia coli from a Multicenter Cohort: Insights into the Phenotypic and Genetic Basis of Coresistance . mSphere.

Nicole J. Tarlton, Charles Moritz, Sheila Adams-Sapper, Lee W. Riley (2019). Genotypic analysis of uropathogenic Escherichia coli to understand factors that impact the prevalence of β-lactam-resistant urinary tract infections in a community . Journal of Global Antimicrobial Resistance.

Tara R. deBoer, Nicole J. Tarlton, Reina Yamaji, Sheila Adams‐Sapper, Tiffany Z. Wu, Santanu Maity, Giri K. Vesgesna, Corinne M. Sadlowski, Peter DePaola, Lee W. Riley, et al. (2018). An Enzyme‐Mediated Amplification Strategy Enables Detection of β‐Lactamase Activity Directly in Unprocessed Clinical Samples for Phenotypic Detection of β‐Lactam Resistance . ChemBioChem.

Sheila Adams-Sapper, Adam Gayoso, Lee. W. Riley(2018). Stress-Adaptive Responses Associated with High-Level Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae . Journal of Pathogens. 2018. p. 1--11. Hindawi Limited

Craig M. Stephens, Sheila Adams-Sapper, Manraj Sekhon, James R. Johnson, Lee W. Riley (2017). Genomic Analysis of Factors Associated with Low Prevalence of Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Sequence Type 95 Strains . mSphere.

Sheila Adams-Sapper, Shantell Nolen, Grace Fox Donzelli, Mallika Lal, Kunihiko Chen, Livia Helena Justo da Silva, Beatriz M. Moreira, Lee W. Riley (2015). Rapid Induction of High-Level Carbapenem Resistance in Heteroresistant KPC-Producing Klebsiella pneumoniae . Antimicrobial Agents and Chemotherapy.

Adriana Hristea, Ioana D. Olaru, Sheila Adams-Sapper, Lee W. Riley (2015). Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study . Infectious Diseases.

Natacha Martins, Renata Cristina Pic&#227;o, Sheila Adams-Sapper, Lee W. Riley, Beatriz Meurer Moreira (2015). Association of Class 1 and 2 Integrons with Multidrug-Resistant Acinetobacter baumannii International Clones and Acinetobacter nosocomialis Isolates . Antimicrobial Agents and Chemotherapy.

Sheila Adams-Sapper, Binh An Diep, Francoise Perdreau-Remington, Lee W. Riley (2013). Clonal Composition and Community Clustering of Drug-Susceptible and -Resistant Escherichia coli Isolates from Bloodstream Infections . Antimicrobial Agents and Chemotherapy.